Waters Co. (WAT) Expected to Post Quarterly Sales of $552.62 Million
Equities research analysts expect Waters Co. (NYSE:WAT) to announce sales of $552.62 million for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for Waters’ earnings. The highest sales estimate is $558.51 million and the lowest is $545.00 million. Waters posted sales of $526.83 million in the same quarter last year, which suggests a positive year-over-year growth rate of 4.9%. The firm is scheduled to announce its next earnings results on Tuesday, October 24th.
According to Zacks, analysts expect that Waters will report full year sales of $552.62 million for the current fiscal year, with estimates ranging from $2.26 billion to $2.29 billion. For the next financial year, analysts forecast that the firm will post sales of $2.39 billion per share, with estimates ranging from $2.37 billion to $2.43 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Waters.
Waters (NYSE:WAT) last posted its quarterly earnings data on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.71 by $0.05. Waters had a return on equity of 21.52% and a net margin of 23.61%. The company had revenue of $558.30 million during the quarter, compared to analyst estimates of $553.22 million. During the same quarter last year, the company earned $1.58 EPS. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis.
A number of equities analysts recently commented on the stock. Bank of America Corporation reissued a “neutral” rating and issued a $192.00 price objective (up previously from $180.00) on shares of Waters in a research note on Friday, July 21st. Deutsche Bank AG downgraded shares of Waters from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $183.00 to $194.00 in a research note on Monday, July 10th. Cowen and Company reissued a “hold” rating and issued a $190.00 price objective on shares of Waters in a research note on Friday, July 14th. Jefferies Group LLC reissued a “hold” rating and issued a $170.00 price objective on shares of Waters in a research note on Friday, July 14th. Finally, Zacks Investment Research downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Wednesday, June 28th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the company. Waters has a consensus rating of “Hold” and an average target price of $186.00.
COPYRIGHT VIOLATION NOTICE: “Waters Co. (WAT) Expected to Post Quarterly Sales of $552.62 Million” was reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.dailypolitical.com/2017/08/06/waters-co-wat-expected-to-post-quarterly-sales-of-552-62-million.html.
In other news, VP Michael F. Silveira sold 620 shares of the stock in a transaction dated Friday, May 12th. The shares were sold at an average price of $172.27, for a total transaction of $106,807.40. Following the sale, the vice president now directly owns 1,688 shares of the company’s stock, valued at approximately $290,791.76. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Rohit Khanna sold 10,000 shares of the stock in a transaction dated Thursday, May 18th. The stock was sold at an average price of $176.46, for a total transaction of $1,764,600.00. Following the sale, the senior vice president now directly owns 14,077 shares in the company, valued at $2,484,027.42. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 98,501 shares of company stock worth $17,695,675. 5.07% of the stock is owned by corporate insiders.
Several large investors have recently bought and sold shares of the company. Watermark Asset Management Inc. bought a new stake in Waters during the first quarter worth about $106,000. First Manhattan Co. acquired a new position in shares of Waters during the second quarter worth $130,000. Creative Planning raised its position in shares of Waters by 1.6% in the first quarter. Creative Planning now owns 744 shares of the medical instruments supplier’s stock worth $116,000 after buying an additional 12 shares in the last quarter. Quadrant Capital Group LLC raised its position in shares of Waters by 4.4% in the first quarter. Quadrant Capital Group LLC now owns 822 shares of the medical instruments supplier’s stock worth $124,000 after buying an additional 35 shares in the last quarter. Finally, Advisory Services Network LLC acquired a new position in shares of Waters during the first quarter worth $169,000. 91.87% of the stock is currently owned by institutional investors and hedge funds.
Waters (WAT) opened at 177.85 on Friday. The company has a market cap of $14.22 billion, a price-to-earnings ratio of 26.80 and a beta of 0.84. Waters has a 52-week low of $133.35 and a 52-week high of $187.65. The company’s 50-day moving average price is $182.20 and its 200-day moving average price is $166.11.
Waters announced that its board has approved a stock repurchase plan on Thursday, May 11th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the medical instruments supplier to repurchase up to 7.3% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its shares are undervalued.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Waters Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Co. and related companies with MarketBeat.com's FREE daily email newsletter.